piribedil and Nausea
piribedil has been researched along with Nausea in 6 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " One of these, piribedil, was administered as 0,1 mg/kg intravenously over 30 minutes to 150 subjects with either migraine or other types of headache." | 3.66 | [Value of the piribedil test in diagnosing migraine. Apropos of 150 cases]. ( Bès, A; Courtade, M; Dupui, P; Géraud, G; Guell, A, 1983) |
| "Piribedil is a dopamine agonist acting on D2 and D3 central nervous system dopamine receptors." | 2.70 | Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers. ( Allain, H; Bentué-Ferrer, D; Gandon, JM; Kleinermans, D; Polard, E; Reymann, JM; Schück, S, 2002) |
| "Patients with migraine show a hypersensitivity to dopamine or its agonists." | 1.27 | Pharmacological exploration of dopamine hypersensitivity in migraine patients. ( Bès, A; Bessoles, G; Dupui, P; Géraud, G; Güell, A, 1986) |
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Tan, EK | 1 |
| Ratnagopal, P | 1 |
| Han, SY | 1 |
| Wong, MC | 1 |
| Géraud, G | 2 |
| Bès, A | 2 |
| Courtade, M | 1 |
| Dupui, P | 2 |
| Guell, A | 2 |
| Schück, S | 1 |
| Bentué-Ferrer, D | 1 |
| Kleinermans, D | 1 |
| Reymann, JM | 1 |
| Polard, E | 1 |
| Gandon, JM | 1 |
| Allain, H | 1 |
| Angrist, B | 1 |
| Ain, M | 1 |
| Rotrosen, J | 1 |
| Gershon, S | 1 |
| Halpern, FS | 1 |
| Sachar, EJ | 1 |
| Milliken, JC | 1 |
| Fares, CM | 1 |
| O'Connor, D | 1 |
| Bessoles, G | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Long-term Therapy With Piribedil (CLARIUM) in Patients With M. Parkinson Under Consideration of Quality of Life Parameters and Cognitive Function[NCT01519856] | 908 participants (Actual) | Observational | 2009-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Trials
3 trials available for piribedil and Nausea
| Article | Year |
|---|---|
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Halluci | 2003 |
Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers.
Topics: Adult; Attention; Cognition; Confusion; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; | 2002 |
[Double-blind study on piribedil in peripheral arterial diseases].
Topics: Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Huma | 1976 |
Other Studies
3 other studies available for piribedil and Nausea
| Article | Year |
|---|---|
[Value of the piribedil test in diagnosing migraine. Apropos of 150 cases].
Topics: Adult; Blood Pressure; Diagnosis, Differential; Female; Headache; Humans; Male; Middle Aged; Migrain | 1983 |
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidol.
Topics: Adult; Dose-Response Relationship, Drug; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Nau | 1979 |
Pharmacological exploration of dopamine hypersensitivity in migraine patients.
Topics: Cerebrovascular Circulation; Domperidone; Dopamine; Headache; Humans; Hypotension; Migraine Disorder | 1986 |